AmCad BioMed Corporation (4188.TWO)
TWD 21.35
(-0.23%)
TWD 21.35
(-0.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 65.25 Million | 61.63 Million | 85.79 Million | 63.94 Million | 84.08 Million |
| Cost of Revenue | 24.23 Million | 23.58 Million | 25.12 Million | 21.6 Million | 21.91 Million |
| Gross Profit | 41.02 Million | 38.04 Million | 60.66 Million | 42.33 Million | 62.17 Million |
| Operating Expenses | 95 Million | 102.39 Million | 97.53 Million | 98.49 Million | 118.46 Million |
| Selling, General and Administrative Expenses | 50.88 Million | 48.39 Million | 46.58 Million | 49.07 Million | 60.14 Million |
| Research and Development Expenses | 44.12 Million | 54 Million | 50.94 Million | 49.42 Million | 58.32 Million |
| Other Expenses | - | 6.93 Million | 7.41 Million | 10.27 Million | - |
| Cost and Expenses | 119.24 Million | 125.97 Million | 122.66 Million | 120.1 Million | 140.37 Million |
| Operating Income | -53.98 Million | -54.27 Million | -26.84 Million | -42.83 Million | -56.28 Million |
| Interest Expense | 123 Thousand | 117 Thousand | 144 Thousand | 91 Thousand | 141 Thousand |
| Income Tax Expense | - | -855 Thousand | -1.34 Million | -7.58 Million | -9.76 Million |
| Earnings before Tax | -43.14 Million | -54.34 Million | -26.89 Million | -43.02 Million | -47.5 Million |
| Net Income | -45.31 Million | -53.48 Million | -25.54 Million | -35.44 Million | -37.74 Million |
| Earnings Per Share Basic | -0.83 | -1.01 | -0.48 | -0.67 | -0.71 |
| Earnings Per Share Diluted | -0.83 | -1.01 | -0.48 | -0.67 | -0.71 |
| Weighted Average Shares Outstanding | 54.41 Million | 53.22 Million | 53.22 Million | 53.17 Million | 52.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.41 Million | 53.22 Million | 53.22 Million | 53.17 Million | 52.97 Million |
| Gross Margin | 0.63 | 0.62 | 0.71 | 0.66 | 0.74 |
| EBIT Margin | -0.39 | -0.59 | -0.10 | -0.36 | -0.53 |
| Profit Margin | -0.69 | -0.87 | -0.30 | -0.55 | -0.45 |
| EBITDA | -25.56 Million | -36.6 Million | -8.46 Million | -23.27 Million | -30.34 Million |
| Earnings Before Tax Margin | -0.83 | -0.88 | -0.31 | -0.67 | -0.67 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 10.51 Million | 16.37 Million | 8.07 Million | 23.41 Million | 65.25 Million | 15.7 Million |
| Cost of Revenue | 4.87 Million | 5.21 Million | 4.76 Million | 7.57 Million | 24.23 Million | 5.44 Million |
| Gross Profit | 5.63 Million | 11.15 Million | 3.31 Million | 15.83 Million | 41.02 Million | 10.26 Million |
| Operating Expenses | 27.73 Million | 23.74 Million | 23.18 Million | 26.36 Million | 95 Million | 24.28 Million |
| Selling, General and Administrative Expenses | - | 12.4 Million | 11.84 Million | 13.65 Million | - | 12.88 Million |
| Research and Development Expenses | - | 11.34 Million | 11.33 Million | 12.71 Million | - | 11.4 Million |
| Other Expenses | -27.73 Million | 438 Thousand | 513 Thousand | 2.28 Million | 6.65 Million | 1.36 Million |
| Cost and Expenses | 32.61 Million | 28.96 Million | 27.94 Million | 33.94 Million | 119.24 Million | 29.73 Million |
| Operating Income | -22.09 Million | -11.12 Million | -18.32 Million | -7.11 Million | -43.02 Million | -11.66 Million |
| Interest Expense | - | 47 Thousand | 52 Thousand | 44 Thousand | 123 Thousand | 37 Thousand |
| Income Tax Expense | - | -927 Thousand | -2.73 Million | 3.74 Million | 2.16 Million | -889 Thousand |
| Earnings before Tax | -19.51 Million | -11.16 Million | -18.37 Million | -7.15 Million | -43.14 Million | -11.7 Million |
| Net Income | -19.51 Million | -10.24 Million | -15.63 Million | -10.9 Million | -45.31 Million | -10.81 Million |
| Earnings Per Share Basic | -0.29 | -0.19 | -0.29 | -0.20 | - | -0.20 |
| Earnings Per Share Diluted | -0.29 | -0.19 | -0.29 | -0.20 | - | -0.20 |
| Weighted Average Shares Outstanding | 66.29 Million | 55.09 Million | 53.27 Million | 53.64 Million | 53.22 Million | 54.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 66.29 Million | 55.09 Million | 53.27 Million | 53.64 Million | 53.22 Million | 54.07 Million |
| Gross Margin | 0.54 | 0.68 | 0.41 | 0.68 | 0.63 | 0.65 |
| EBIT Margin | -2.10 | -0.39 | -1.69 | -0.12 | - | -0.46 |
| Profit Margin | -1.86 | -0.63 | -1.94 | -0.47 | -0.69 | -0.69 |
| EBITDA | -22.09 Million | -6.43 Million | -13.64 Million | -2.74 Million | - | -7.3 Million |
| Earnings Before Tax Margin | -2.10 | -0.68 | -2.27 | -0.30 | -0.66 | -0.74 |
JSL
0HWH
2291
TLL
GEM
9869